Position in SANA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$19,034,107
-$7,864,787 QoQ
Shares Held
6,609,065
0.0% QoQ
Ownership
2.21%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in SANA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,034,107 | 6,609,065 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $26,898,894 | 6,609,065 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $40,599,583 | 11,436,503 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $27,476,706 | 10,064,728 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $17,121,678 | 10,191,476 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $16,680,722 | 10,233,573 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $42,756,827 | 10,278,084 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $57,718,750 | 10,571,200 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $106,562,790 | 10,656,279 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $41,412,067 | 10,150,017 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $39,490,929 | 10,204,375 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $64,583,517 | 10,836,161 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $35,567,555 | 10,876,929 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $42,520,670 | 10,764,727 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $65,800,416 | 10,966,736 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $70,803,699 | 11,011,462 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $91,569,211 | 11,085,861 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $174,336,223 | 11,262,030 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $251,995,014 | 11,189,832 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $221,014,788 | 11,241,851 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $334,283,129 | 9,987,545 | Shares | Defined | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||